Standout Papers
- Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin‐induced thrombocytopenia in two clinical settings (2006)
- Heparin-induced thrombocytopenia and cardiac surgery (2003)
- Impact of the patient population on the risk for heparin-induced thrombocytopenia (2000)
- A 14-year study of heparin-induced thrombocytopenia (1996)
- Temporal Aspects of Heparin-Induced Thrombocytopenia (2001)
- American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia (2018)
- Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination (2021)
- Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated Heparin (1995)
- Treatment and Prevention of Heparin-Induced Thrombocytopenia (2008)
Citation Impact
Citing Papers
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Subcutaneous Fondaparinux versus Intravenous Unfractionated Heparin in the Initial Treatment of Pulmonary Embolism
2003
Reversal of Rivaroxaban and Dabigatran by Prothrombin Complex Concentrate
2011
The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia
2011 Standout
The management of heparin‐induced thrombocytopenia
2006
Expansive discovery of chemically diverse structured macrocyclic oligoamides
2024 StandoutScienceNobel
Heparin-induced thrombocytopenia (HIT)
2006
Platelet factor 4–induced T H 1-T reg polarization suppresses antitumor immunity
2024 StandoutScienceNobel
Nonheparin Anticoagulants for Heparin-Induced Thrombocytopenia
2013
Prospective Randomised Open-label Comparison of Danaparoid with Dextran 70 in the Treatment of Heparin-induced Thrombocytopaenia with Thrombosis
2001
Anticoagulant Use in Patients with Chronic Renal Impairment
2005
ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
2007
Modulation of Integrin Activation by an Entropic Spring in the β-Knee
2010 StandoutNobel
Immobilization of the direct thrombin inhibitor‐bivalirudin on 316L stainless steel via polydopamine and the resulting effects on hemocompatibility in vitro
2012
Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism
2001
Heparininduzierte Thrombozytopenie als Komplikation der postoperativen Thromboseprophylaxe mit UFH/NMH-Heparinen nach Hüft- und Knieendoprothetik
2002
A meta-analysis of thromboembolic prophylaxis in total knee arthroplasty
2001
A unique, low dose of intravenous enoxaparin in elective percutaneous coronary intervention
2002
Pharmacology and Management of the Vitamin K Antagonists
2008 Standout
Subcutaneous Enoxaparin Once or Twice Daily Compared with Intravenous Unfractionated Heparin for Treatment of Venous Thromboembolic Disease
2001
Incidence and clinical significance of anti‐PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin‐induced thrombocytopenia
2006
Thromboembolic Disease after Total Hip Arthroplasty
2006
Prospective evaluation of a new platelet glycoprotein (GP)-specific assay (PakAuto) in the diagnosis of autoimmune thrombocytopenia (AITP)
2005
Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety
2001 Standout
Low-molecular-weight heparin for the long-term treatment of symptomatic venous thromboembolism: meta-analysis of the randomized comparisons with oral anticoagulants
2003
Low Molecular Weight Heparin
1997
PULSED HIGH-DOSE DEXAMETHASONE THERAPY IN CHILDREN WITH CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA
2002
Prospective evaluation of the immunobead assay for the diagnosis of adult chronic immune thrombocytopenic purpura (ITP)
2003
Prevention of venous thromboembolism
2001
Pathogenesis and therapy of psoriasis
2007 StandoutNature
Heparin is not required for detection of antibodies associated with heparin-induced thrombocytopenia/thrombosis
2001
Platelet functions beyond hemostasis
2009
Oral Anticoagulant Therapy
2012 Standout
Heparin-Induced Thrombocytopenia Following Cardiac Surgery is Associated With Poor Outcome
2006
Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism
2012
Benefit of Heparin in Central Venous and Pulmonary Artery Catheters
1998
Venous Thromboembolism Is Rare with a Multimodal Prophylaxis Protocol after Total Hip Arthroplasty
2006
Enoxaparin vs heparin for prevention of deep-vein thrombosis in acute ischaemic stroke: a randomized, double-blind study
2002
Comparison of Low Molecular Weight Heparin (Fragmin) With Sodium Heparin for Prophylaxis Against Postoperative Thrombosis in Women Undergoing Major Gynaecological Surgery
1998
Integrins Form an Expanding Diffusional Barrier that Coordinates Phagocytosis
2016 StandoutNobel
Heparin-induced thrombocytopenia with thrombosis: Incidence, analysis of risk factors, and clinical outcomes in 108 consecutive patients treated at a single institution
1997
Heparin-Induced Thrombocytopenia
1998
Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, part 2: Treatment
2009
Argatroban Anticoagulation in Patients With Heparin-Induced Thrombocytopenia
2003
The Incidence of Recognized Heparin-Induced Thrombocytopenia in a Large, Tertiary Care Teaching Hospital
2007
Randomised, controlled trial of low-dose heparin for prevention of fatal pulmonary embolism in patients with infectious diseases
1996
Prevention of Venous Thromboembolic Disease After Total Hip and Knee Arthroplasty
2005
Autoantibodies and autoantigens in chronic immune thrombocytopenic purpura
2000
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
2009 Standout
Inflammation and coagulation
2010
Severe Sepsis and Septic Shock
2013 Standout
Unstable Angina Pectoris
2000
Incidence of heparin-PF4 complex antibody formation and heparin-induced thrombocytopenia in acute coronary syndrome
2004
Enoxaparin for thromboprophylaxis after major trauma: Potential cost implications
2001
Thromboprophylaxis with 60 mg Enoxaparin Is Safe in Hip Trauma Surgery
2001
Indigenous Bacteria from the Gut Microbiota Regulate Host Serotonin Biosynthesis
2015 Standout
Initial Treatment of Immune Thrombocytopenic Purpura with High-Dose Dexamethasone
2003
Failure of early heparin cessation as treatment for heparin-induced thrombocytopenia
1999
Prevention of central venous line-related thrombosis by continuous infusion of low-dose unfractionated heparin, in patients with haemato-oncological disease
2004
The Effect of a Computerized Reminder System on the Prevention of Postoperative Venous Thromboembolism
2004
The Pharmacokinetics and Pharmacodynamics of Argatroban: Effects of Age, Gender, and Hepatic or Renal Dysfunction
2000
Risk factors for thrombosis in patients with immune mediated heparin‐induced thrombocytopenia
2002
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
2009 Standout
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy
2020 Standout
Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functions
2005
Thrombocytopenia in Patients With an Acute Coronary Syndrome (from the Global Registry of Acute Coronary Events [GRACE])
2008
Safety, pharmacodynamics, and pharmacokinetics of single doses of BAY 59-7939, an oral, direct factor Xa inhibitor
2005
Diagnostic score for heparin‐induced thrombocytopenia after cardiopulmonary bypass
2004
Heparin and Low-Molecular-Weight Heparin
2004
The ATP-gated P2X1 Receptor Plays a Pivotal Role in Activation of Aspirin-treated Platelets by Thrombin and Epinephrine
2008 StandoutNobel
Incidence and clinical relevance of heparin‐induced antibodies in patients with deep vein thrombosis treated with unfractionated or low‐molecular‐weight heparin
2002
Use of Antithrombotic Agents During Pregnancy
2004
Twice vs Three Times Daily Heparin Dosing for Thromboembolism Prophylaxis in the General Medical Population
2007
Low-Molecular-Weight Heparin for the Treatment of Acute Ischemic Stroke
1995
Immune Thrombocytopenic Purpura
2002 Standout
Heparin-Induced Thrombocytopenia
2006 Standout
Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer
2004
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
2009 Standout
Frequency of anti‐heparin‐platelet factor 4 antibodies in hemodialysis patients and correlation with recurrent vascular access thrombosis
2001
Frequency of Heparin‐Induced Thrombocytopenia in Critical Care Patients
2003
The effect of pre-operative aspirin on bleeding, transfusion, myocardial infarction, and mortality in coronary artery bypass surgery: a systematic review of randomized and observational studies
2008
The 2007 ABJS Nicolas Andry Award: Three Decades of Clinical, Basic, and Applied Research on Thromboembolic Disease after THA
2007
ISTH interim guidance on recognition and management of coagulopathy in COVID‐19
2020
Malignant Gliomas in Adults
2008 Standout
HEPARIN-INDUCED THROMBOCYTOPENIA, PARADOXICAL THROMBOEMBOLISM, AND OTHER SIDE EFFECTS OF HEPARIN THERAPY
1998
High-dose dexamethasone as a first- and second-line treatment of idiopathic thrombocytopenic purpura in adults
2004
Prevention of Venous Thromboembolism
2004 Standout
The Hazards of Scoring the Quality of Clinical Trials for Meta-analysis
1999 Standout
Immunohaemostasis: a new view on haemostasis during sepsis
2017
Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer
2003 Standout
Venous Thromboembolism, Thrombophilia, Antithrombotic Therapy, and Pregnancy
2008
Heparin‐induced thrombocytopenia and thrombosis: clinical and laboratory studies
1993
Guidelines for the Use of Retrievable and Convertible Vena Cava Filters: Report from the Society of Interventional Radiology Multidisciplinary Consensus Conference
2006
Randomized, Controlled Trials, Observational Studies, and the Hierarchy of Research Designs
2000 Standout
Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages
2020 Standout
Comparison of Enoxaparin and Warfarin for the Prevention of Venous Thromboembolic Disease After Total Hip Arthroplasty. Evaluation During Hospitalization and Three Months After Discharge*
1999
Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, Part 1: Prevention
2009
Splenic Radiation for Corticosteroid-resistant Immune Thrombocytopenia
1992
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
2000 Standout
Prevention of Venous Thromboembolism
2008 Standout
Use of Low Molecular Weight Heparin in Preventing Thromboembolism in Trauma Patients
1996
Heparin‐induced thrombocytopenia: An international assessment of the quality of laboratory testing
2019
Antithrombotic Therapy in Neonates and Children
2008
A facile, sensitive and selective fluorescent probe for heparin based on aggregation-induced emission
2013
Advances in the diagnosis of idiopathic thrombocytopenic purpura
2000
The Determinants of Activated Partial Thromboplastin Time, Relation of Activated Partial Thromboplastin Time to Clinical Outcomes, and Optimal Dosing Regimens for Heparin Treated Patients with Acute Coronary Syndromes: A Review of GUSTO-IIb
2002
Glypican-1 identifies cancer exosomes and detects early pancreatic cancer
2015 StandoutNature
The Pathophysiology of Heparin-Induced Thrombocytopenia
2005
A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa
2013
VTE, Thrombophilia, Antithrombotic Therapy, and Pregnancy
2012
Heparin‐induced multi‐electrode aggregometry method for heparin‐induced thrombocytopenia testing: communication from the SSC of the ISTH
2016
Heparin-induced thrombocytopenia is rare in pregnancy
2001
A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery Disease
1997 Standout
The Pharmacology and Management of the Vitamin K Antagonists
2004 Standout
Warfarin-Induced Skin Necrosis and Venous Limb Gangrene in the Setting of Heparin-Induced Thrombocytopenia
2004
Randomized, pilot study of intermittent pneumatic compression devices plus dalteparin versus intermittent pneumatic compression devices plus heparin for prevention of venous thromboembolism in patients undergoing craniotomy
2003
Deep vein thrombosis
2005
Safety and Efficacy of Enoxaparin vs Unfractionated Heparin in Patients With Non–ST-Segment Elevation Acute Coronary Syndromes Who Receive Tirofiban and Aspirin<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
2004
The Venous Thrombotic Risk in Nonsurgical Patients
1996
Initial laboratory findings useful for predicting the diagnosis of idiopathic thrombocytopenic purpura
2005
Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation: a meta-analysis
2000
Unanticipated variations between expected and delivered pneumatic compression therapy after elective hip surgery
2001
Selective room temperature phosphorescence detection of heparin based on manganese-doped zinc sulfide quantum dots/polybrene self-assembled nanosensor
2015
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Management of Anticoagulation before and after Elective Surgery
1997
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
2011 Standout
Lepirudin in patients with heparin-induced thrombocytopenia – results of the third prospective study (HAT-3) and a combined analysis of HAT-1, HAT-2, and HAT-3
2005
Trends in peptide drug discovery
2021
Heparin-induced multiple electrode aggregometry is a promising and useful functional tool for heparin-induced thrombocytopenia diagnosis: Confirmation in a prospective study
2012
1 Epidemiology, risk factors and prophylaxis of venous thrombo-embolism in obstetrics and gynaecology
1997
[Guidelines for the management of patients with atrial fibrillation. Executive summary].
2006
A Nitro‐Modified Luminescent Hydrogen‐Bonded Organic Framework for Non‐Contact and High‐Contrast Sensing of Aromatic Amines
2023 StandoutNobel
Venous thromboembolism in trauma patients: A review
2001
Heparin-induced thrombocytopenia with thromboembolic complications: meta-analysis of 2 prospective trials to assess the value of parenteral treatment with lepirudin and its therapeutic aPTT range
2000
QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies
2011 Standout
Eptifibatide-induced thrombocytopenia: with thrombosis and disseminated intravascular coagulation immediately after left main coronary artery percutaneous coronary angioplasty.
2012
Low molecular weight heparin for the prevention of venous thromboembolism after abdominal surgery
2004
Regulatory T Cells Control PF4/Heparin Antibody Production in Mice
2019
Studies of Fibrinogen Binding to Platelets by Flow Cytometry: An Improved Method for Studies of Platelet Activation
1992 StandoutNobel
Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: an explanation for the thrombotic complications of heparin-induced thrombocytopenia
1994
How I treat disseminated intravascular coagulation
2017
Ardeparin (low-molecular-weight heparin) vs graduated compression stockings for the prevention of venous thromboembolism. A randomized trial in patients undergoing knee surgery.
1996
Platelet-Derived Serotonin Mediates Liver Regeneration
2006 Science
Lepirudin for prophylaxis of thrombosis in patients with acute isolated heparin-induced thrombocytopenia: an analysis of 3 prospective studies
2004
The GPIIb/IIIa (integrin αIIbβ3) odyssey: a technology-driven saga of a receptor with twists, turns, and even a bend
2008
Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy
2005
PF-4/CXCL4 and CXCL4L1 exhibit distinct subcellular localization and a differentially regulated mechanism of secretion
2007
Low Molecular Weight Heparin
1997
Recombinant Hirudin (Lepirudin) Provides Safe and Effective Anticoagulation in Patients With Heparin-Induced Thrombocytopenia
1999
Oral Rivaroxaban for Symptomatic Venous Thromboembolism
2010 Standout
Fondaparinux or Enoxaparin for the Initial Treatment of Symptomatic Deep Venous Thrombosis
2004
Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation
2001 Standout
Rapid anticoagulation using ancrod for heparin-induced thrombocytopenia [see comments]
1991
The incidence of heparin-induced thrombocytopenia in medical patients treated with low-molecular-weight heparin: a prospective cohort study
2005
Hirudin in Acute Myocardial Infarction
1996
Chronic Thromboembolic Pulmonary Hypertension and Pulmonary Thromboendarterectomy
2005
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
High sensitivity and specificity of a new functional flow cytometry assay for clinically significant heparin‐induced thrombocytopenia antibodies
2013
Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack
2006 Standout
Platelet Factor 4/Heparin Antibodies in Blood Bank Donors
2010
Delayed-Onset Heparin-Induced Thrombocytopenia
2002
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
Thrombocytopenia in the Intensive Care Unit Patient
2010
Fluorescent detection of heparin by a cationic conjugated polyfluorene probe containing aggregation-induced emission units
2011
Management of Venous Thromboembolism in Patients With Primary and Metastatic Brain Tumors
2006
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
2020 Standout
Anaphylactic and Anaphylactoid Reactions Associated With Lepirudin in Patients With Heparin-Induced Thrombocytopenia
2003
First Trimester Stroke Prophylaxis in Pregnant Women With a History of Stroke
2009
Heparin-induced thrombocytopenia in neurologic patients treated with low-molecular-weight heparin
2005
Water-soluble bioprobes with aggregation-induced emission characteristics for light-up sensing of heparin
2014
Polydopamine and Its Derivative Materials: Synthesis and Promising Applications in Energy, Environmental, and Biomedical Fields
2014 Standout
B-cell tolerance regulates production of antibodies causing heparin-induced thrombocytopenia
2013
CalDAG-GEFI deficiency protects mice in a novel model of FcγRIIA-mediated thrombosis and thrombocytopenia
2011
Minimizing the Risks of Anticoagulants and Platelet Inhibitors
2010
Clinical Significance of Thrombocytopenia During a Non–ST-Elevation Acute Coronary Syndrome
1999
A multicenter randomized double-blind study of enoxaparin compared with unfractionated heparin in the prevention of venous thromboembolic disease in elderly in-patients bedridden for an acute medical illness. The Enoxaparin in Medicine Study Group.
1996
COVID-19 and its implications for thrombosis and anticoagulation
2020 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
The Role of the Bone Marrow Examination in the Diagnosis of Immune Thrombocytopenic Purpura: Case Series and Literature Review
2002
Low-molecular-weight heparin in the management of Tyrousseau's syndrome
1997
Prevention of deep vein thrombosis after hip replacement--comparison between two low-molecular heparins, tinzaparin and enoxaparin.
1999
Use of Antithrombotic Agents During Pregnancy
1995
Use of the Low-Molecular-Weight Heparin Reviparin to Prevent Deep-Vein Thrombosis after Leg Injury Requiring Immobilization
2002
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation—Executive Summary
2006
Low-Molecular-Weight Heparins
1997 Standout
A cell protection screen reveals potent inhibitors of multiple stages of the hepatitis C virus life cycle
2010 StandoutNobel
Managing anticoagulant and antiplatelet drugs in patients who are receiving neuraxial anesthesia and epidural analgesia: a practical guide for clinicians
2006
Thromboembolic Prophylaxis in Moderate‐Risk Patients Undergoing Elective Abdominal Surgery: Decision and Cost‐Effectiveness Analyses
1996
Deep venous thrombosis prophylaxis in trauma: improved compliance with a novel miniaturized pneumatic compression device
2003
Heparin-induced thrombocytopenia with thromboembolic complications: meta-analysis of 2 prospective trials to assess the value of parenteral treatment with lepirudin and its therapeutic aPTT range
2000
Comparison of Unfractionated Versus Low Molecular Weight Heparin for Deep Vein Thrombosis Prophylaxis During Breast and Pelvic Cancer Surgery: Efficacy, Safety, and Follow-up
1998
Use of intravenous immunoglobulin G to treat spontaneous heparin‐induced thrombocytopenia
2018
Lepirudin (Recombinant Hirudin) for Parenteral Anticoagulation in Patients With Heparin-Induced Thrombocytopenia
1999
Prevention of Venous Thromboembolism
1995
The incidence of heparin-induced thrombocytopenia in hospitalized medical patients treated with subcutaneous unfractionated heparin: a prospective cohort study
2003
Randomized Trial of Prevention of Catheter-Related Bloodstream Infection by Continuous Infusion of Low-Dose Unfractionated Heparin in Patients With Hematologic and Oncologic Disease
2005
Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination
2021 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack
2010 Standout
Low molecular weight heparins versus unfractionated heparin for acute coronary syndromes
2003
Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients
2005
High-Dose Atorvastatin after Stroke or Transient Ischemic Attack
2006 Standout
Oral Vitamin K Versus Placebo to Correct Excessive Anticoagulation in Patients Receiving Warfarin
2009
Prevention of Deep Vein Thrombosis after Hip Replacement
1999
Argatroban Anticoagulant Therapy in Patients With Heparin-Induced Thrombocytopenia
2001 Standout
Prevention and Treatment of Thrombo-embolic Disease in Gynaecological Surgery
1999
Low‐Molecular‐Weight Heparin versus Warfarin for Prevention of Recurrent Venous Thromboembolism: A Randomized Trial
1996
Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis
2005 Standout
Hematological Problems in Pediatric Intensive Care
2013 Standout
Antibodies to Platelet Factor 4–Heparin After Cardiopulmonary Bypass in Patients Anticoagulated With Unfractionated Heparin or a Low-Molecular-Weight Heparin
1999
A novel flow cytometry–based platelet aggregation assay
2013
Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination
2021 Standout
Works of Theodore E. Warkentin being referenced
Heparin-Induced Thrombocytopenia and its Treatment
2000
Limitations of conventional treatment options for heparin-induced thrombocytopenia.
1998
Heparin-induced thrombocytopenia in intensive care patients
2007
An Overview of the Heparin-Induced Thrombocytopenia Syndrome
2004
Morphological analysis of microparticle generation in heparin-induced thrombocytopenia
2000
Platelet Count Monitoring and Laboratory Testing for Heparin-Induced Thrombocytopenia
2002
Drug-Induced Immune-Mediated Thrombocytopenia — From Purpura to Thrombosis
2007
Laboratory testing for the antibodies that cause heparin-induced thrombocytopenia: How much class do we need?
2005
Proposal of a two‐step process for the diagnosis of sepsis‐induced disseminated intravascular coagulation
2019
An international external quality assessment for laboratory diagnosis of heparin‐induced thrombocytopenia
2019
Approach to the Diagnosis and Management of Drug-Induced Immune Thrombocytopenia
2013
Heparin‐induced thrombocytopenia: pathogenesis and management
2003
Laboratory Testing for Heparin-Induced Thrombocytopenia
2000
An Improved Definition of Immune Heparin-Induced Thrombocytopenia in Postoperative Orthopedic Patients
2003
Heparin-Induced Thrombocytopenia: Recognition, Treatment, and Prevention
2004
Bivalirudin: a review
2005
Heparin-Induced thrombocytopenia: IgG-Mediated platelet activation, platelet microparticle generation, and altered procoagulant/anticoagulant balance in the pathogenesis of thrombosis and venous limb gangrene complicating heparin-Induced thrombocytopenia
1996
Management of heparin-induced thrombocytopenia: a critical comparison of lepirudin and argatroban
2003
Managing bleeding in anticoagulated patients with a focus on novel therapeutic agents
2009
Heparin‐induced thrombocytopenia: a prospective study on the incidence, platelet‐activating capacity and clinical significance of antiplatelet factor 4/heparin antibodies of the IgG, IgM, and IgA classes
2007
Immune heparin-induced thrombocytopenia can occur in patients receiving clopidogrel and aspirin
2005
New Approaches to the Diagnosis of Heparin-Induced Thrombocytopenia
2005
A Spontaneous Prothrombotic Disorder Resembling Heparin-induced Thrombocytopenia
2008
Immunoassays are not created equal
2009
Diagnosis and management of sepsis‐induced coagulopathy and disseminated intravascular coagulation
2019
Treatment and Prevention of Heparin-Induced Thrombocytopenia
2008 Standout
Heparin-induced thrombocytopenia
1998
Temporal Aspects of Heparin-Induced Thrombocytopenia
2001 Standout
Venous limb gangrene during overlapping therapy with warfarin and a direct thrombin inhibitor for immune heparin‐induced thrombocytopenia
2002
Failure of pulse high-dose dexamethasone in chronic idiopathic immune thrombocytopenia
1997
The 4Ts scoring system for heparin-induced thrombocytopenia in medical-surgical intensive care unit patients
2010
Suboptimal effect of a three‐factor prothrombin complex concentrate (Profilnine‐SD) in correcting supratherapeutic international normalized ratio due to warfarin overdose
2009
Bivalent direct thrombin inhibitors: hirudin and bivalirudin
2004
Early‐onset and persisting thrombocytopenia in post‐cardiac surgery patients is rarely due to heparin‐induced thrombocytopenia, even when antibody tests are positive
2009
Prevalence and Risk of Preexisting Heparin-Induced Thrombocytopenia Antibodies in Patients With Acute VTE
2011
High‐dose intravenous immunoglobulin to treat spontaneous heparin‐induced thrombocytopenia syndrome
2019
Off-pump coronary artery bypass grafting for acute heparin-induced thrombocytopenia
2001
Prevalence and clinical implications of anti-PF4/heparin antibodies in intensive care patients: a prospective observational study
2014
Clinical features of heparin-induced thrombocytopenia including risk factors for thrombosis
2005
Differential diagnoses for sepsis‐induced disseminated intravascular coagulation: communication from the SSC of the ISTH
2018
What is the potential for overdiagnosis of heparin‐induced thrombocytopenia?
2007
Current Concepts in the Treatment of Immune Thrombocytopenia
1990
Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin‐induced thrombocytopenia in two clinical settings
2006 Standout
Quantitative interpretation of optical density measurements using PF4‐dependent enzyme‐immunoassays
2008
Differences in the clinically effective molar concentrations of four direct thrombin inhibitors explain their variable prothrombin time prolongation
2005
Autoimmune heparin‐induced thrombocytopenia
2017
Heparin-Induced Skin Lesions and Other Unusual Sequelae of the Heparin-Induced Thrombocytopenia Syndrome
2005
Recognition, treatment, and prevention of heparin-induced thrombocytopenia: Review and update
2005
Measurement of fibrinogen binding to platelets in whole blood by flow cytometry: a micromethod for the detection of platelet activation
1990
Heparin-induced thrombocytopenia in the critical care setting: Diagnosis and management^
2006
Thrombocytopenia associated with the use of GPIIb/IIIa inhibitors: position paper of the ISTH working group on thrombocytopenia and GPIIb/IIIa inhibitors
2006
Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated Heparin
1995 Standout
Heparin-induced thrombocytopenia and cardiac surgery
2003 Standout
Serum-induced platelet procoagulant activity: An assay for the characterization of prothrombotic disorders
1999
A 14-year study of heparin-induced thrombocytopenia
1996 Standout
Heparin-induced thrombocytopenia and cardiac surgery
2003
Platelet-Endothelial Interactions: Sepsis, HIT, and Antiphospholipid Syndrome
2003
Think of HIT
2006
Multicentric warfarin-induced skin necrosis complicating heparin-induced thrombocytopenia
1999
Results of a systematic evaluation of treatment outcomes for heparin-induced thrombocytopenia in patients receiving danaparoid, ancrod, and/or coumarin explain the rapid shift in clinical practice during the 1990s
2005
Transient global amnesia associated with acute heparin-induced thrombocytopenia
1994
Cellular immune responses to platelet factor 4 and heparin complexes in patients with heparin‐induced thrombocytopenia
2018
Warfarin Cessation Before Cardiopulmonary Bypass: Lessons Learned from a Randomized Controlled Trial of Oral Vitamin K
2007
Heparin‐induced skin lesions
1996
Laboratory testing for heparin-induced thrombocytopenia is inconsistent in North America: A survey of North American specialized coagulation laboratories
2007
Thrombocytopenia in medical-surgical critically ill patients: prevalence, incidence, and risk factors
2005
Studies of the anti–platelet factor 4/heparin immune response: adapting the enzyme‐linked immunosorbent spot assay for detection of memory B cells against complex antigens
2009
Activation of platelets by sera containing igg1 heparin-dependent antibodies: an explanation for the predominance of the Fcγrlla “low responder” (his131) gene in patients with heparin-induced thrombocytopenia
1997
Heparin-Induced Thrombocytopenia
1997
Clinical picture of heparin-induced thrombocytopenia (HIT) and its differentiation from non-HIT thrombocytopenia
2016
Agents for the Treatment of Heparin-Induced Thrombocytopenia
2010
Heparin-induced thrombocytopenia in patients requiring prolonged intensive care unit treatment after cardiopulmonary bypass
2008
A prospective study of protein‐specific assays used to investigate idiopathic thrombocytopenic purpura
1999
HITlights: A career perspective on heparin‐induced thrombocytopenia
2012
High-dose intravenous immunoglobulin for the treatment and prevention of heparin-induced thrombocytopenia: a review
2019
Factor V Leiden and Thrombotic Complications in Heparin-induced Thrombocytopenia
1998
Impact of the patient population on the risk for heparin-induced thrombocytopenia
2000 Standout
Delayed-Onset Heparin-Induced Thrombocytopenia and Thrombosis
2001
Heparin-Induced Thrombocytopenia: A Ten-Year Retrospective
1999
Gender imbalance and risk factor interactions in heparin-induced thrombocytopenia
2006
Heparin-induced thrombocytopenia: a historical perspective
2008
Determinants of donor platelet variability when testing for heparin-induced thrombocytopenia.
1992
Effect of fondaparinux on platelet activation in the presence of heparin-dependent antibodies: a blinded comparative multicenter study with unfractionated heparin
2004
Heparin-Induced Thrombocytopenia in Critically Ill Patients
2015
Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: a systematic review and meta-analysis
2012
Venous Limb Gangrene during Warfarin Treatment of Cancer-Associated Deep Venous Thrombosis
2001
Heparin-induced Thrombocytopenia: Towards Consensus
1998
Heparin-Induced Thrombocytopenia: A Clinicopathologic Syndrome
1999
Combination of 4Ts score and PF4/H-PaGIA for diagnosis and management of heparin-induced thrombocytopenia: prospective cohort study
2015
Anti–platelet factor 4/heparin antibodies in orthopedic surgery patients receiving antithrombotic prophylaxis with fondaparinux or enoxaparin
2005
Heparin-induced Thrombocytopenia: Yet Another Treatment Paradox?
2001
Cerebral venous sinus thrombosis associated with spontaneous heparin-induced thrombocytopenia syndrome after total knee arthroplasty
2020
Studies of the immune response in heparin-induced thrombocytopenia
2009
Heparin-Induced Thrombocytopenia
2004
Laboratory diagnosis of immune heparin-induced thrombocytopenia.
2003
Bleeding risk and the management of bleeding complications in patients undergoing anticoagulant therapy: focus on new anticoagulant agents
2008
Heparin-Induced Thrombocytopenia
2003
Heparin and Platelets
1990
Advance in the Management of Sepsis-Induced Coagulopathy and Disseminated Intravascular Coagulation
2019
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination
2021 Standout
Heparin: Mechanism of Action, Pharmacokinetics, Dosing Considerations, Monitoring, Efficacy, and Safety
1995
A diagnostic test for heparin‐induced thrombocytopenia: detection of platelet microparticles using flow cytometry
1996
Central venous catheters and upper-extremity deep-vein thrombosis complicating immune heparin-induced thrombocytopenia
2003
Spontaneous HIT syndrome post-knee replacement surgery with delayed recovery of thrombocytopenia: a case report and literature review
2017
Replacement of unfractionated heparin by low-molecular-weight heparin for postorthopedic surgery antithrombotic prophylaxis lowers the overall risk of symptomatic thrombosis because of a lower frequency of heparin-induced thrombocytopenia
2005
How I Diagnose and Manage HIT
2011
Should Aspirin Be Discontinued Before Coronary Artery Bypass Surgery?
2005
Ischemic Limb Gangrene with Pulses
2015
Reversing anticoagulants both old and new.
2003
Temporal aspects of heparin-induced thrombocytopenia
2001
Heparin-Induced Thrombocytopenia
2005
Impact of the patient population on the risk for heparin-induced thrombocytopenia
2000